PRP guidelines · Indian

Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy

Himanshu Bansal, Jerry Leon, Jeremy L. Pont, David A. Wilson, Anupama Bansal, Diwaker Agarwal & Iustin Preoteasa

Scientific Reports · 2021

In brief

A randomised clinical trial comparing platelet-rich plasma (PRP), made with a refined manual preparation method, against hyaluronic acid in knee osteoarthritis over a year. The authors report better pain, function and walking results and lower inflammation markers with PRP, and argue that delivering a sufficiently high total platelet count is key to lasting benefit.

Read the original paper (opens in a new tab)

Citation, as listed in the PRP guidelines

Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy Authors: Himanshu Bansal, Jerry Leon, Jeremy L. Pont, David A. Wilson, Anupama Bansal, Diwaker Agarwal & Iustin Preoteasa Link: https://search.app/9ewKvjSuZqi7s4Vu7 Year of Publication: 2021

A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.

More from the PRP guidelines

Ready to rewrite your health story?

Request a callback from our team.